A. Silvani

发表

Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma: A Randomized Clinical Trial.

Thomas C. Chen, F. Lieberman, R. Stupp, 2015, JAMA.

Psychological features and quality of life in 50 adult patients with epilepsy and their caregivers from the Lecco epilepsy center, Italy

A. Silvani, A. Salmaggi, A. Petruzzi, 2017, Epilepsy & Behavior.

Safety and efficacy of primary central nervous system lymphoma treatment in elderly population

A. Silvani, E. Lamperti, G. Simonetti, 2015, Neurological Sciences.

Circulating T regulatory cells migration and phenotype in glioblastoma patients: an in vitro study

A. Silvani, A. Salmaggi, A. Rizzo, 2013, Journal of Neuro-Oncology.

Medulloblastoma of the adult: results from a multicenter retrospective study by AINO (Italian Association of Neuro-Oncology) and SIN (Italian Society of Neurology)

A. Silvani, A. Salmaggi, M. Farinotti, 2020, Neurological Sciences.

Safety of bevacizumab in patients with malignant gliomas: a systematic review

A. Silvani, A. Salmaggi, E. Lamperti, 2013, Neurological Sciences.

Misdiagnosis of post-traumatic splenic rupture in a patient with acute cold agglutinin disease due to Mycoplasma infection.

A. Silvani, G. Barosi, L. Cirasino, 1997, Scandinavian journal of infectious diseases.

Expression of Drug Resistance Proteins Pgp, MRP1, MRP3, MRP5 AND GST-π in Human Glioma

C. Marras, A. Silvani, C. Calatozzolo, 2005, Journal of Neuro-Oncology.

Advantage of treating anaplastic gliomas with aggressive protocol combining chemotherapy and radiotherapy

G. Broggi, A. Silvani, A. Salmaggi, 1997, Journal of Neuro-Oncology.

Effectiveness of Early Chemotherapy Treatment in Anaplastic Astrocytoma Patients

A. Silvani, A. Franzini, A. Salmaggi, 1995, Tumori.

Effects of Thalidomide on Parameters Involved in Angiogenesis: An in vitro Study

G. Broggi, A. Silvani, B. Pollo, 2003, Journal of Neuro-Oncology.

Decrease in circulating endothelial progenitor cells in treated glioma patients

A. Silvani, C. Calatozzolo, A. Salmaggi, 2012, Journal of Neuro-Oncology.

Multicentre prospective collection of newly diagnosed glioblastoma patients: update on the Lombardia experience

G. Tomei, A. Silvani, M. Caroli, 2008, Neurological Sciences.

A multicentre prospective collection of newly diagnosed glioblastoma patients in Lombardia, Italy

G. Tomei, A. Silvani, E. Marchioni, 2005, Neurological Sciences.

Phase II Trial of Cisplatin Plus Temozolomide, in Recurrent and Progressive Malignant Glioma Patients

G. Broggi, A. Silvani, E. Maccagnano, 2004, Journal of Neuro-Oncology.

Cranial sonolucent prosthesis: a window of opportunity for neuro-oncology (and neuro-surgery)

L. Solbiati, A. Silvani, F. DiMeco, 2022, Journal of Neuro-Oncology.

Reclassification of oligoastrocytomas by loss of heterozygosity studies

G. Broggi, A. Silvani, G. Finocchiaro, 2006, International journal of cancer.

Adult brainstem glioma: a multicentre retrospective analysis of 47 Italian patients

A. Silvani, A. Salmaggi, G. Spena, 2020, Neurological Sciences.

Pattern of care and outcome in elderly patients with glioblastoma: Data in 151 patients from 3 Lombardia Hospitals

A. Silvani, A. Salmaggi, A. Rigamonti, 2017, Journal of the Neurological Sciences.

Production and post-surgical modification of VEGF, tPA and PAI-1 in patients with glioma

C. Marras, A. Silvani, B. Pollo, 2006, Cancer biology & therapy.

The role of the neurologist

A. Silvani, M. Eoli, A. Salmaggi, 2005, Neurological Sciences.

CXCL12 Expression is Predictive of a Shorter Time to Tumor Progression in Low-Grade Glioma: A Single-Institution Study in 50 Patients

C. Marras, G. Broggi, A. Silvani, 2005, Journal of Neuro-Oncology.

Circulating intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1) and plasma thrombomodulin levels in glioblastoma patients.

A. Silvani, M. Eoli, A. Salmaggi, 1999, Cancer letters.

Systemic sagopilone (ZK-EPO) treatment of patients with recurrent malignant gliomas

A. Silvani, V. Scaioli, M. Eoli, 2009, Journal of Neuro-Oncology.

Chemotherapy is effective as early treatment for primary central nervous system lymphoma

G. Broggi, A. Silvani, A. Salmaggi, 1999, Journal of Neurology.

Radiotherapy at tumor recurrence in primary CNS lymphoma

A. Silvani, A. Salmaggi, A. Boiardi, 1998, Neurology.

In vitro and in vivo stability and anti-tumour efficacy of an anti-EGFR/anti-CD3 F(ab')2 bispecific monoclonal antibody.

A. Silvani, S. Canevari, S. Sforzini, 1995, British Journal of Cancer.

Treatment of recurrent glioblastoma: can local delivery of mitoxantrone improve survival?

G. Broggi, A. Silvani, G. Filippini, 2008, Journal of Neuro-Oncology.

Systemic Temozolomide Combined with Loco-regional Mitoxantrone in Treating Recurrent Glioblastoma

G. Broggi, A. Silvani, G. Finocchiaro, 2005, Journal of Neuro-Oncology.

Tumor necrosis factor microsatellite polymorphisms in Italian glioblastoma patients.

A. Silvani, A. Salmaggi, S. Frigerio, 1999, Cancer genetics and cytogenetics.

Neuro-telehealth for fragile patients in a tertiary referral neurological institute during the COVID-19 pandemic in Milan, Lombardy

M. de Curtis, A. Silvani, P. Tiraboschi, 2021, Neurological Sciences.

Natural history and postsurgical outcome of syringomyelia

L. Munari, A. Silvani, A. Scuratti, 1991, The Italian Journal of Neurological Sciences.

Loco-regional immunotherapy with recombinant interleukin-2 and adherent lymphokine-activated killer cells (A-LAK) in recurrent glioblastoma patients

G. Broggi, A. Silvani, A. Salmaggi, 1994, Cancer Immunology, Immunotherapy.

Factors, including transforming growth factor β, released in the glioblastoma residual cavity, impair activity of adherent lymphokine-activated killer cells

A. Silvani, G. Parmiani, L. Rivoltini, 1993, Cancer Immunology, Immunotherapy.

Prospective observational study on the complications and tolerability of a peripherally inserted central catheter (PICC) in neuro-oncological patients

A. Silvani, C. Ricci, G. Simonetti, 2019, Supportive Care in Cancer.

Intracerebral haemorrhage in primary and metastatic brain tumours

A. Silvani, B. Pollo, A. Erbetta, 2008, Neurological Sciences.

Intrathecal synthesis of onconeural antibodies in patients with paraneoplastic syndromes

A. Silvani, L. Chiapparini, A. Salmaggi, 2016, Journal of Neuroimmunology.

Extra central nervous system metastases from glioblastoma: a new possible trigger event?

A. Silvani, A. Hottinger, G. Simonetti, 2017, Neurological Sciences.

Poster Session

E. Parati, A. Silvani, A. Erbetta, 1978, Neurological Sciences.

RETRACTED ARTICLE: Headaches and brain tumors

A. Silvani, A. Salmaggi, E. Lamperti, 2012, Neurological Sciences.

Polycystic Lipomembranous Osteodysplasia with Sclerosing Leukoencephalopathy (PLOSL): A new report of an Italian woman and review of the literature

A. Silvani, L. Piccio, A. Salmaggi, 2013, Journal of the Neurological Sciences.

Primary cerebral non-Hodgkin's lymphoma (PCNSL): a review of new trends in management

A. Silvani, A. Boiardi, Dr. A. Boiardi, 2005, The Italian Journal of Neurological Sciences.

Association of chromosome 10 losses and negative prognosis in oligoastrocytomas

G. Broggi, A. Silvani, G. Finocchiaro, 2002, Annals of neurology.

Infections in neuro-oncology

A. Silvani, A. Salmaggi, E. Lamperti, 2011, Neurological Sciences.

Intratumoral delivery of mitoxantrone in association with 90-Y radioimmunotherapy (RIT) in recurrent glioblastoma

G. Broggi, A. Silvani, M. Eoli, 2005, Journal of Neuro-Oncology.

Efficacy of intratumoral delivery of mitoxantrone in recurrent malignant glial tumours

G. Broggi, A. Silvani, M. Eoli, 2001, Journal of Neuro-Oncology.

Locally delivered chemotherapy and repeated surgery can improve survival in glioblastoma patients

G. Broggi, A. Silvani, M. Eoli, 1999, The Italian Journal of Neurological Sciences.

Neoplastic Meningitis from Solid Tumors: A Prospective Clinical Study in Lombardia and a Literature Review on Therapeutic Approaches

A. Silvani, M. Caroli, A. Salmaggi, 2013, Journal of drug delivery.

Combined chemotherapy and radiotherapy for intracranial germinomas in adultpatients: a single-institution study

G. Broggi, A. Silvani, M. Eoli, 2005, Journal of Neuro-Oncology.

Local drug delivery in recurrent malignant gliomas

G. Broggi, A. Silvani, A. Solari, 2005, Neurological Sciences.

Prognostic value of CXCL12 expression in 40 low-grade oligodendrogliomas and oligoastrocytomas

C. Marras, A. Silvani, C. Calatozzolo, 2006, Cancer biology & therapy.

Acute late-onset encephalopathy after radiotherapy: An unusual life-threatening complication

F. Ducray, P. Vitali, A. Silvani, 2013, Neurology.

Update on treatment strategies for anaplastic glioma: a review of literature

A. Silvani, E. Lamperti, G. Simonetti, 2014, Neurological Sciences.

Hidden reality: sexual sphere in brain tumor patients

A. Silvani, A. Petruzzi, C. Finocchiaro, 2017, Psychology, health & medicine.

M-Bacod as first treatment for primary CNS lymphoma

A. Silvani, A. Salmaggi, A. Boiardi, 1996, Neurology.

CXCL12 in Malignant Glial Tumors: A Possible Role in Angiogenesis and Cross-Talk between Endothelial and Tumoral Cells

G. Broggi, A. Silvani, B. Pollo, 2004, Journal of Neuro-Oncology.

Natural history and management of brainstem gliomas in adults

A. Bizzi, R. Soffietti, A. Silvani, 2008, Journal of Neurology.

Methotrexate based chemotherapy and deferred radiotherapy for primary central nervous system lymphoma (PCNSL): single institution experience

C. Marras, G. Broggi, A. Silvani, 2007, Journal of Neuro-Oncology.

Neoadjuvant chemotherapy in the treatment of recurrent glioblastomas (GBM)

A. Silvani, D. Croci, A. Boiardi, 1992, The Italian Journal of Neurological Sciences.

Fotemustine Combined with Procarbazine in Recurrent Malignant Gliomas: A Phase I Study with Evaluation of Lymphocyte O6-alkylguanine–DNA Alkyltransferase Activity

A. Silvani, G. Margison, A. Watson, 2001, Journal of Neuro-Oncology.

Interstitial chemotherapy with mitoxantrone in recurrent malignant glioma: preliminary data

G. Broggi, A. Silvani, A. Salmaggi, 1996, Journal of Neuro-Oncology.

Intra-arterial ACNU and carboplatin versus intravenous chemotherapy with cisplatin and BCNU in newly diagnosed patients with glioblastoma

A. Silvani, A. Erbetta, M. Eoli, 2002, Neurological Sciences.

Embryonal tumors in the adult population: implications in therapeutic planning

A. Silvani, M. Eoli, A. Salmaggi, 2000, Neurological Sciences.

Primary glial tumor patients treated by combining cis-platin and etoposide

G. Broggi, A. Silvani, A. Boiardi, 1991, Journal of Neuro-Oncology.

Loco-regional treatments in first-diagnosis glioblastoma: literature review on association between Stupp protocol and Gliadel

A. Silvani, A. Salmaggi, P. Gaviani, 2011, Neurological Sciences.

Neuro-oncological diagnosis in patients without histological confirmation

A. Silvani, A. Salmaggi, E. Lamperti, 2011, Neurological Sciences.

Headache in brain tumours: a symptom to reappraise critically

A. Silvani, M. Eoli, A. Salmaggi, 2004, Neurological Sciences.

Intrathecal immunotherapy in CNS tumors disseminating via CSF: preliminary evaluation using different treatment schedules

A. Silvani, A. Salmaggi, A. Dufour, 1996, The Italian Journal of Neurological Sciences.

Cerebral venous thrombosis associated with extracranial tumours : a clinical series

G. Comi, A. Silvani, A. Salmaggi, 2014 .

Combined chemotherapy with temozolomide and fotemustine in recurrent glioblastoma patients

A. Silvani, A. Salmaggi, P. Gaviani, 2011, Journal of Neuro-Oncology.

Cisplatin and etoposide combination therapy for primary glial tumors: Preliminary results

L. Munari, A. Silvani, A. Boiardi, 1991, The Italian Journal of Neurological Sciences.

The role of body mass index in the development of thromboembolic events among cancer patients with PICCs: a systematic review.

A. Silvani, I. Tramacere, P. Gaviani, 2021, Journal of vascular nursing : official publication of the Society for Peripheral Vascular Nursing.

Tumour-associated epilepsy: clinical impact and the role of referring centres in a cohort of glioblastoma patients. A multicentre study from the Lombardia Neurooncology Group

G. Tomei, A. Silvani, E. Marchioni, 2006, Neurological Sciences.

Cisplatinum and BCNU chemotherapy in primary glioblastoma patients

A. Silvani, F. DiMeco, A. Erbetta, 2009, Journal of Neuro-Oncology.

Multicenter, single arm, phase II trial on the efficacy of ortataxel in recurrent glioblastoma

V. Torri, A. Silvani, M. Caroli, 2019, Journal of Neuro-Oncology.

Methylation of O6-Methylguanine DNA Methyltransferase and Loss of Heterozygosity on 19q and/or 17p Are Overlapping Features of Secondary Glioblastomas with Prolonged Survival

Maria Grazia Bruzzone, Graziella Filippini, Ludovico D'Incerti, 2007, Clinical Cancer Research.

Neuron specific enolase (NSE) and thymidine kinase (TK) as markers in biological fluids of brain tumor patients

L. Munari, A. Silvani, E. Bombardieri, 1990, The Italian Journal of Neurological Sciences.

Genetic and Plasma Markers of Venous Thromboembolism in Patients with High Grade Glioma

E. Parati, A. Silvani, A. Salmaggi, 2004, Clinical Cancer Research.

Salvage chemotherapy with procarbazine and fotemustine combination in the treatment of temozolomide treated recurrent glioblastoma patients

A. Silvani, G. Filippini, M. Eoli, 2008, Journal of Neuro-Oncology.

IDH wild-type grade 2 diffuse astrocytomas: prognostic factors and impact of treatments within molecular subgroups.

E. Migliore, R. Soffietti, A. Silvani, 2021, Neuro-oncology.

Cognitive awareness after treatment for high-grade glioma

A. Silvani, A. Giovagnoli, R. Meneses, 2021, Clinical Neurology and Neurosurgery.

Anaplasia Is Rare and Does Not Influence Prognosis in Adult Medulloblastoma

A. Chiò, A. Silvani, B. Pollo, 2005, Journal of neuropathology and experimental neurology.

Bevacizumab at recurrence in high-grade glioma

A. Silvani, A. Salmaggi, E. Lamperti, 2011, Neurological Sciences.

Italian consensus and recommendations on diagnosis and treatment of low-grade gliomas. An intersocieties (SINch/AINO/SIN) document.

F. Angileri, A. Falini, A. Olivi, 2020, Journal of neurosurgical sciences.

Local immunotherapy (β-IFN) and systemic chemotherapy in primary glial tumors

L. Munari, G. Broggi, A. Silvani, 1991, The Italian Journal of Neurological Sciences.

Prognostic nutritional index as a prognostic marker in glioblastoma: Data from a cohort of 282 Italian patients

V. Torri, A. Silvani, A. Salmaggi, 2019, Journal of the Neurological Sciences.

Poor metabolization of n-hexane in Parkinson's disease

M. Canesi, G. Pezzoli, A. Silvani, 2003, Journal of Neurology.

Immunological fluctuations during intrathecal immunotherapy in three patients affected by CNS tumours disseminating via CSF.

A. Silvani, A. Salmaggi, A. Dufour, 1994, The International journal of neuroscience.

Cerebrospinal fluid interleukin‐10 levels in primary central nervous system lymphoma: A possible marker of response to treatment?

A. Silvani, M. Eoli, A. Salmaggi, 2000, Annals of neurology.

Recurrent brain tumour: the impact of illness on patient's life

G. Pantaleo, A. Silvani, A. Salmaggi, 2012, Supportive Care in Cancer.

Herpes simplex encephalitis in glioma patients: a challenging diagnosis

M. Sanson, F. Baldanti, P. Vitali, 2014, Journal of Neurology, Neurosurgery & Psychiatry.

Characterization of an established human, malignant, glioblastoma cell line (GBM) and its response to conventional drugs

A. Silvani, F. Zunino, P. Perego, 2005, Journal of Cancer Research and Clinical Oncology.

Survival effect of first- and second-line treatments for patients with primary glioblastoma: a cohort study from a prospective registry, 1997-2010.

A. Silvani, F. DiMeco, G. Finocchiaro, 2014, Neuro-oncology.

Pathways of follow-up care in an Italian center: retrospective study on patients with gliomas II and III

A. Silvani, M. Leonardi, E. Lamperti, 2021, Neurological Sciences.

Successful adoptive immunotherapy with lymphokine-activated killer cells in the treatment of medulloblastoma disseminated via cerebrospinal fluid: case report.

A. Silvani, A. Salmaggi, G. Parmiani, 1994, Neurosurgery.

A. Kanner, M. Mehdorn, S. Pannullo, 2017, Journal of Neuro-Oncology.

Molecular markers of gliomas: a clinical approach

G. Broggi, F. Menghi, A. Silvani, 2006, Neurological research.

Clinical management of grade iii oligodendroglioma

A. Silvani, E. Lamperti, G. Simonetti, 2015 .

Sustained Tumor Control With MAPK Inhibition in BRAF V600–Mutant Adult Glial and Glioneuronal Tumors

K. Hoang-Xuan, F. Ducray, M. Sanson, 2021, Neurology.

Intrathecal synthesis of tumor markers is a highly sensitive test in the diagnosis of leptomeningeal metastasis from solid cancers

A. Silvani, A. Salmaggi, P. Gaviani, 2009, Clinical chemistry and laboratory medicine.

CXCL12, CXCR4 and CXCR7 expression in brain metastases

A. Silvani, F. Di Meco, C. Calatozzolo, 2009, Cancer biology & therapy.

Biweekly fotemustine schedule for recurrent glioblastoma in the elderly: activity and toxicity assessment of a multicenter study

M. Caraglia, A. Silvani, R. Addeo, 2019, CNS oncology.

Neoplastic meningitis from breast carcinoma with complete response to liposomal cytarabine: case report

A. Silvani, A. Erbetta, A. Salmaggi, 2009, Neurological Sciences.

Antiepileptic treatment and survival in newly diagnosed glioblastoma patients: Retrospective multicentre study in 285 Italian patients

V. Torri, A. Silvani, A. Salmaggi, 2018, Journal of the Neurological Sciences.

Interstitial Chemotherapy Plus Systemic Chemotherapy for Glioblastoma Patients: Improved Survival in Sequential Studies

G. Broggi, A. Silvani, A. Salmaggi, 2004, Journal of Neuro-Oncology.

Radiosurgery reirradiation for high-grade glioma recurrence: a retrospective analysis

P. Ferroli, A. Silvani, F. DiMeco, 2015, Neurological Sciences.

Reversible Valproate Induced Pisa Syndrome and Parkinsonism in a Neuro-Oncology Patient with Depression and Epilepsy

G. Pravettoni, A. Silvani, C. Lucchiari, 2016, Case Reports in Neurology.

Prospective study of carmustine wafers in combination with 6-month metronomic temozolomide and radiation therapy in newly diagnosed glioblastoma: preliminary results.

A. Silvani, F. DiMeco, B. Pollo, 2013, Journal of neurosurgery.

Efficacy of ‘8-drugs-in-one-day’ combination in treatment of recurrent GBM patients

G. Broggi, A. Silvani, L. Fariselli, 1992, Journal of Neuro-Oncology.

Chemotherapy as first treatment for primary malignant non-Hodgkin's lymphoma of the central nervous system preliminary data

G. Broggi, A. Silvani, A. Salmaggi, 1993, Journal of Neurology.

Clinical and radiological features of brain neurotoxicity caused by antitumor and immunosuppressant treatments

A. Silvani, A. Erbetta, A. Salmaggi, 2008, Neurological Sciences.

Short Course Radiotherapy Concomitant with Temozolomide in GBM Patients: A Phase II Study

A. Silvani, L. Cuppini, F. DiMeco, 2017, Tumori.

Cisplatin and BCNU Chemotherapy for Anaplastic Oligoastrocytomas

G. Broggi, A. Silvani, B. Pollo, 2000, Journal of Neuro-Oncology.

Intracavitary VEGF, bFGF, IL-8, IL-12 levels in primary and recurrent malignant glioma

G. Broggi, A. Silvani, M. Eoli, 2003, Journal of Neuro-Oncology.

Antineuronal Antibody in a Patient with Neuroblastoma and Opsoclonus-Myoclonus-Ataxia: A Case Report

A. Silvani, R. Nemni, A. Salmaggi, 1997, Tumori.

Facets and determinants of quality of life in patients with recurrent high grade glioma

A. Silvani, A. Giovagnoli, E. Colombo, 2005, Journal of Neurology, Neurosurgery & Psychiatry.

Long term follow up in 183 high grade meningioma: A single institutional experience

A. Silvani, B. Pollo, A. Erbetta, 2021, Clinical Neurology and Neurosurgery.

Effective long-term temozolomide rechallenge in a macroprolactinoma

A. Silvani, G. Simonetti, R. Attanasio, 2018, Endocrinology, diabetes & metabolism case reports.

Anthropometrics and Body Composition in Adults with High-Grade Gliomas: Effects of Disease-Related Variables

A. Silvani, A. Battezzati, A. Leone, 2018, Nutrition and cancer.

Vitamin E neuroprotection for cisplatin neuropathy

A. Silvani, V. Scaioli, F. Cognetti, 2010, Neurology.

Quality of life and brain tumors: what beyond the clinical burden?

A. Silvani, A. Giovagnoli, A. Salmaggi, 2014, Journal of Neurology.

Cognitive strategies and quality of life of patients with high-grade glioma

G. Pravettoni, A. Silvani, C. Lucchiari, 2015, Supportive Care in Cancer.

Caring for Brain Tumour Patients: Psychological Reactions After Bereavement

A. Silvani, A. Salmaggi, A. Petruzzi, 2015, Journal of palliative care.

Erratum: Salvage chemotherapy with procarbazine and fotemustine combination in the treatment of temozolomide treated recurrent glioblastoma patients (J Neurooncol (2008) vol. 87 (143-151) (10.1007/ s11060-007-9427-y))

A. Silvani, G. Filippini, M. Eoli, 2008 .

May we deliver neuro-oncology in difficult times (e.g. COVID-19)?

P. Ferroli, A. Silvani, F. DiMeco, 2020, Journal of Neuro-Oncology.

Brain tuberculoma (Mycobacterium africanum): high index of suspicion helps in avoiding biopsy/surgery

E. Prodi, A. Silvani, A. Salmaggi, 2012, Neurological Sciences.

Isocaloric Ketogenic Diet in Adults with High-Grade Gliomas: A Prospective Metabolic Study

A. Silvani, A. Battezzati, A. Leone, 2020, Nutrition and cancer.

Distribution of daunorubicin and daunorubicinol in human glioma tumors after administration of liposomal daunorubicin

M. Zucchetti, A. Silvani, M. D’Incalci, 1999, Cancer Chemotherapy and Pharmacology.

The burden of brain tumor: a single-institution study on psychological patterns in caregivers

A. Silvani, A. Salmaggi, A. Petruzzi, 2012, Journal of Neuro-Oncology.

Liposomal cytarabine in neoplastic meningitis from primary brain tumors: a single institutional experience

A. Silvani, B. Pollo, A. Erbetta, 2013, Neurological Sciences.

Short-course radiotherapy in elderly patients with glioblastoma: feasibility and efficacy of results from a single centre

A. Silvani, A. Salmaggi, M. Farinotti, 2013, Strahlentherapie und Onkologie.

[Experience with the intrathecal use of liposomal cytarabine at the Besta Institute].

A. Silvani, 2007, Tumori.

Metabolic, electrolytes disorders and tromboembolic risk in malignant glioma patients

A. Silvani, A. Salmaggi, E. Lamperti, 2011, Neurological Sciences.

New perspectives: Glioma in adult patients

A. Silvani, 2023, Tumori.

A case of medulloblastoma in adult patient affected by anaplastic oligoastrocytoma

A. Silvani, B. Pollo, E. Lamperti, 2016, Neurological Sciences.

Cisplatin neuropathy in brain tumor chemotherapy

A. Silvani, V. Scaioli, D. Pareyson, 1992, The Italian Journal of Neurological Sciences.

Temozolomide and cisplatin in the treatment of leptomeningeal metastatic involvement from melanoma: a case report

A. Silvani, M. Eoli, A. Salmaggi, 2002, Neurological Sciences.

Psychosocial factors associated with workability after surgery in cancer survivors: An explorative study.

A. Silvani, M. Leonardi, S. Di Cosimo, 2023, Journal of health psychology.

Vitamin E in the neuroprotection of cisplatin induced peripheral neurotoxicity and ototoxicity

A. Silvani, F. Cognetti, A. Pace, 2007 .

Adult medulloblastoma: multiagent chemotherapy with cisplatinum and etoposide: a single institutional experience

P. Ferroli, A. Silvani, F. DiMeco, 2012, Journal of Neuro-Oncology.

Malignant gliomas: early diagnosis and clinical aspects

A. Silvani, A. Salmaggi, E. Lamperti, 2011, Neurological Sciences.

PL3.2 Trabectedin for recurrent WHO grade II or III meningioma: a randomized phase II study of the EORTC Brain Tumor Group (EORTC-1320-BTG)

C. Marosi, T. Gorlia, R. Soffietti, 2019, Neuro-Oncology.

Trabectedin for recurrent WHO grade II or III meningioma: A randomized phase II study of the EORTC Brain Tumor Group (EORTC-1320-BTG).

M. Weller, C. Marosi, T. Gorlia, 2019, Journal of Clinical Oncology.

Trabectedin for recurrent WHO grade 2 or 3 meningioma: a randomized phase 2 study of the EORTC Brain Tumor Group (EORTC-1320-BTG).

J. Pichler, M. Weller, C. Marosi, 2021, Neuro-oncology.

Poster Session

P. Chimento, A. Silvani, C. Lucchiari, 2021, Neurological Sciences.

Employment and Work Ability of Persons With Brain Tumors: A Systematic Review

A. Silvani, M. Leonardi, A. Raggi, 2020, Frontiers in Human Neuroscience.

Rechallenge with temozolomide in recurrent glioma

A. Silvani, A. Salmaggi, E. Lamperti, 2011, Neurological Sciences.

ATCT-35QUALITY OF LIFE, COGNITIVE FUNCTION AND FUNCTIONAL STATUS IN THE EF-14 TRIAL: A PROSPECTIVE, MULTI-CENTER TRIAL OF TTFIELDS WITH TEMOZOLOMIDE COMPARED TO TEMOZOLOMIDE ALONE IN PATIENTS WITH NEWLY DIAGNOSED GBM

R. Stupp, A. Olivi, Z. Ram, 2015 .

Safety and potential effectiveness of daunorubicin-containing liposomes in patients with advanced recurrent malignant CNS tumors

M. Zucchetti, A. Silvani, M. Eoli, 1999, Cancer Chemotherapy and Pharmacology.

Lecture: fotemustine in brain tumors

A. Silvani, A. Salmaggi, E. Lamperti, 2011, Neurological Sciences.

Treatment of gliomatosis cerebri with temozolomide: A retrospective study of the AINO (Italian Association for Neuro- Oncology)

R. Soffietti, A. Silvani, M. Caroli, 2007 .

Preliminary data by cis-platin and etoposide using in primary glioblastoma.

L. Munari, A. Silvani, A. Boiardi, 1990, Journal of neurosurgical sciences.

Modification of phlogosis indices in pneumonia during antibiotic therapy.

A. Silvani, S. del Guerra, S. Ragaini, 1995, Recenti progressi in medicina.

A diagnostic circulating miRNA signature as orchestrator of cell invasion via TKS4/TKS5/EFHD2 modulation in human gliomas

A. Silvani, B. Pollo, A. Sacconi, 2023, Journal of Experimental & Clinical Cancer Research.

Gliomatosis cerebri (GC) or GC-like? A picture to be reconsidered in neuro-oncology based on large retrospective analysis of GC series

A. Silvani, F. DiMeco, B. Pollo, 2020, Neurological Sciences.

Stroke‐like events after brain radiotherapy: a large series with long‐term follow‐up

F. Ducray, A. Silvani, B. Giometto, 2019, European journal of neurology.

Repurposing Chlorpromazine as add-on in the adjuvant phase of first-line glioblastoma therapeutic protocol in patients carrying hypo-/un-methylated MGMT gene promoter: RACTAC, a Phase II multicenter single arm clinical trial

A. Silvani, P. Gaviani, D. Giannarelli, 2023, medRxiv.

Antineuronal Antibodies in Patients with Neuroblastoma: Relationships with Clinical Features

A. Silvani, R. Nemni, A. Salmaggi, 1997, Tumori.

Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma: A Randomized Clinical Trial.

F. Lieberman, R. Stupp, S. Toms, 2015, JAMA.

Italian Guidelines for the Management of Prolactinomas

E. Papini, F. Esposito, P. Cappabianca, 2023, Endocrine, metabolic & immune disorders drug targets.

Methylation of O6-Methylguanine DNA Methyltransferase and Loss of Heterozygosity on 19q and/or 17p Are Overlapping Features of Secondary Glioblastomas with Prolonged Survival

G. Broggi, F. Menghi, A. Silvani, 2007, Clinical Cancer Research.

Safety of second-line chemotherapy with non-conventional fotemustine schedule in recurrent high grade gliomas: a single institution experience

A. Silvani, A. Salmaggi, E. Lamperti, 2013, Journal of Neuro-Oncology.

Survival effect of first- and second-line treatments for patients with primary glioblastoma: a cohort study from a prospective registry, 1997-2010.

A. Silvani, F. DiMeco, G. Finocchiaro, 2014, Neuro-oncology.

Tumor treating fields (TTFields): A novel treatment modality added to standard chemo- and radiotherapy in newly diagnosed glioblastoma—First report of the full dataset of the EF14 randomized phase III trial.

F. Lieberman, R. Stupp, S. Toms, 2015 .